News | Radiation Dose Management | December 11, 2020

Bayer Radiology Announces Transformation of Radimetrics

New functionality advances optimization of workflow and enhances dose management to improve quality, efficiency and compliance

Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application.

December 11, 2020 — Bayer Radiology is announcing Radimetrics v3.0, the newest evolution of its enterprise dose management application. The newly designed system supports many of the latest accreditation standards on dose reporting and tracking, protocol management, and benchmarking, along with offering the latest in cyber security.

Radimetrics 3.0 helps patient-care teams report, track, and manage radiation dose and contrast dose throughout the chain of care with increased functionality and features, including:

  • Upgraded front-end user interface for easier navigation and optimization of workflow
  • Easy visualization and expanded dose analytics; including new summary page library to intuitively establish benchmarks and inform point-of care decisions
  • Data tracking to improve billing processes
  • Enhanced alerting notifications of outlier data and consolidation of dose reference levels to help users advance patient safety measures
  • Virtual CE training modules (ASRT accredited)
  • Positioned for future innovations including expanded Fluoroscopy capabilities, cloud-based deployments, enhanced benchmarking and AI insights

“The advancement in the design and functional improvement in workflow was positively received throughout our human factors design analysis with Radimetrics 3.0 users," said Adam Czibur, Bayer Senior Factors Engineer. “Following their testing experience, users described their experience as quicker, easier to navigate and providing workflow flexibility, and reported higher levels of usability and comfortability compared to Radimetrics v2.x”.

In addition, Radimetrics v3.0 leverages HTML5 standards to address the latest cyber security updates, and provide protection against future vulnerabilities, while addressing the obsolescence of Adobe Flash technology. The conversion to HTML5 prepares our Radimetrics customers for future cloud configurations, AI solutions, and new injector platforms.

“The launch of Radimetrics represents an important advancement in utilizing digital platforms for analyzing data to optimize standardization, and problem-solve in real time,” said Dennis Durmis, Head of Radiology Americas, “Its specialty focused interface design, new capabilities, and comprehensive training approach, will drive standardization for personalized care for patients.”

Bayer is a worldwide leading provider of medical devices and services, providing customers with innovative products, on-site applications support and unmatched equipment service.

For more information: www.bayer.us

Related Content

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

New Module Creates a Warped MRI Scan that Matches Real-Time Ultrasound Results (Graphic: Business Wire)

News | Artificial Intelligence | May 07, 2021
3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

3D aMRI not only provides a stunning look inside the "beating brain", but it can also measure this physiological motion in all directions. Here, the amplitude of brain motion is overlayed for each brain slice and orientation in 3D. Image credit: 3D aMRI method outlined in Abderezaei et al. Brain Multiphysics (2021); Terem et al. Magnetic Resonance in Medicine (2021).

News | Magnetic Resonance Imaging (MRI) | May 06, 2021
May 6, 2021 — Magnetic Resonance Imaging
Research finds that a commonly used risk-prediction model for lung cancer does not accurately identify high-risk Black patients who could benefit from early screening

Getty Images

News | Lung Imaging | May 05, 2021
May 5, 2021 — Lung cancer is the third most common cance
After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by

After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by N. Galldiks et al., Research Center Juelich, Juelich, Germany.

News | PET Imaging | May 05, 2021
May 5, 2021 — For patients with brain metastases, amino acid ...
When working with a vendor on project implementation, it is critical to focus on the actual execution of the implementation

Getty Images

Feature | Radiology Business | May 05, 2021 | By Jef Williams
You have selected a vendor. Congratulations.